Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| CTXR | CITIUS PHARMACEUTICALS INC | $6.45M | 8,593,433 | 5.22% | 94.78% | ||||
| VOR | VOR BIOPHARMA INC | $18.85M | 124,851,547 | 48.80% | 36.97% | Net Selling | Net Selling | ||
| BTAI | BIOXCEL THERAPEUTICS INC | $8.39M | 5,486,038 | 4.15% | 95.85% | Net Selling | |||
| PALI | PALISADE BIO INC | $3.32M | 4,396,646 | 2.35% | 97.65% | Net Selling | |||
| IMNN | IMUNON INC | $11.70M | 14,620,732 | 2.91% | 63.41% | Net Buying | |||
| GBIO | GENERATION BIO CO | $24.13M | 67,035,236 | 63.57% | 36.43% | Net Buying | Net Selling | ||
| PASG | PASSAGE BIO INC | $20.45M | 62,148,274 | 44.81% | 55.19% | Net Selling | Net Selling | ||
| INAB | IN8BIO INC | $14.25M | 90,771,944 | 33.08% | 25.77% | Net Buying | Net Buying | ||
| XFOR | X4 PHARMACEUTICALS INC | $19.51M | 5,788,686 | 92.13% | 7.87% | Net Selling | |||
| TNYA | TENAYA THERAPEUTICS INC | $67.34M | 162,666,931 | 26.83% | 23.55% | Net Buying | Net Buying | ||
| ACRV | ACRIVON THERAPEUTICS INC | $36.37M | 31,351,480 | 60.75% | 39.25% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $11.22M | 16,999,626 | 2.82% | 97.18% | Net Buying | |||
| OKUR | ONKURE THERAPEUTICS INC | $25.94M | 13,510,399 | 34.13% | 65.87% | Net Buying | Net Selling | ||
| ANVS | ANNOVIS BIO INC | $29.81M | 19,486,231 | 8.09% | 15.05% | ||||
| CODX | CO-DIAGNOSTICS INC | $11.46M | 33,712,530 | 16.97% | 28.22% | Net Selling | |||
| FBLG | FIBROBIOLOGICS INC | $31.36M | 37,735,300 | 15.74% | 16.01% | Net Buying | |||
| HUMA | HUMACYTE INC | $184.59M | 155,118,816 | 27.13% | 22.31% | Net Selling | Net Buying | ||
| INZY | INOZYME PHARMA INC | $73.88M | 64,240,198 | 55.76% | 44.24% | Net Selling | Net Selling | ||
| CLNN | CLENE INC | $23.62M | 8,982,747 | 1.24% | 98.76% | Net Buying | Net Selling | ||
| ANNX | ANNEXON INC | $175.54M | 109,709,826 | 81.65% | 18.35% | Net Buying | Net Selling | ||
| AFMD | AFFIMED NV | $11.23M | 16,392,343 | 17.10% | 0.00% | ||||
| NRXP | NRX PHARMACEUTICALS INC | $34.51M | 16,915,647 | 2.19% | 97.81% | Net Buying | |||
| IMRX | IMMUNEERING CORP | $41.02M | 35,985,702 | 11.96% | 38.58% | Net Buying | |||
| IGC | IGC PHARMA INC | $23.75M | 79,685,165 | 3.56% | 23.32% | Net Buying | |||
| AMTX | AEMETIS INC | $71.43M | 55,369,358 | 9.85% | 90.15% | Net Buying | Net Buying | ||
| CANF | CAN-FITE BIOPHARMA LTD | $9.93M | 2,983,181,793 | 0.00% | 0.00% | ||||
| INTS | INTENSITY THERAPEUTICS INC | $8.18M | 15,180,945 | 17.92% | 13.22% | Net Buying | |||
| FBIO | FORTRESS BIOTECH INC | $49.91M | 29,533,840 | 16.23% | 50.96% | Net Buying | Net Buying | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $41.96M | 57,481,679 | 6.64% | 38.47% | Net Selling | |||
| KAPA | KAIROS PHARMA LTD | $11.37M | 16,693,306 | 2.44% | 40.60% | Net Buying | |||
| CYBN | CYBIN INC | $141.01M | 20,001,406 | 34.58% | 0.00% | ||||
| OVID | OVID THERAPEUTICS INC | $20.61M | 71,075,005 | 66.93% | 24.07% | Net Selling | Net Selling | ||
| CABA | CABALETTA BIO INC | $60.38M | 50,743,101 | 75.81% | 8.32% | ||||
| IVVD | INVIVYD INC | $77.50M | 119,961,445 | 45.59% | 54.41% | Net Selling | |||
| CGTX | COGNITION THERAPEUTICS INC | $18.66M | 61,993,046 | 17.86% | 41.06% | Net Selling | Net Selling | ||
| GOVX | GEOVAX LABS INC | $14.10M | 15,193,593 | 0.11% | 99.89% | Net Buying | Net Buying | ||
| JSPR | JASPER THERAPEUTICS INC | $67.90M | 15,022,122 | 23.83% | 76.17% | Net Buying | |||
| OCGN | OCUGEN INC | $195.65M | 292,014,470 | 24.48% | 10.45% | Net Selling | |||
| SNSE | SENSEI BIOTHERAPEUTICS INC | $9.07M | 25,208,068 | 9.31% | 71.61% | Net Selling | Net Selling | ||
| IMUX | IMMUNIC INC | $91.05M | 90,150,869 | 56.66% | 17.23% | Net Buying | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $35.90M | 44,873,646 | 48.45% | 51.55% | Net Buying | Net Buying | ||
| PRME | PRIME MEDICINE INC | $170.68M | 131,294,454 | 38.69% | 61.31% | ||||
| APLT | APPLIED THERAPEUTICS INC | $56.63M | 141,575,526 | 81.28% | 8.04% | Net Selling | Net Selling | ||
| FDMT | 4D MOLECULAR THERAPEUTICS INC | $142.68M | 46,324,642 | 78.75% | 21.25% | Net Buying | |||
| CARM | CARISMA THERAPEUTICS INC | $7.98M | 41,788,096 | 11.70% | 73.98% | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $38.33M | 46,739,949 | 16.54% | 22.85% | ||||
| CBUS | CIBUS INC | $73.68M | 34,350,784 | 20.30% | 79.70% | Net Buying | Net Selling | ||
| UNCY | UNICYCIVE THERAPEUTICS INC | $65.84M | 119,705,026 | 51.54% | 11.83% | ||||
| ENLV | ENLIVEX THERAPEUTICS LTD | $24.12M | 23,650,989 | 14.42% | 60.76% | ||||
| ARTV | ARTIVA BIOTHERAPEUTICS INC | $50.68M | 24,363,119 | 57.35% | 42.65% | Net Buying | |||
| LCTX | LINEAGE CELL THERAPEUTICS INC | $100.48M | 228,356,290 | 41.22% | 58.78% | Net Buying | |||
| FEMY | FEMASYS INC | $28.87M | 27,239,885 | 8.59% | 6.53% | ||||
| ZURA | ZURA BIO LTD | $74.87M | 61,874,998 | 52.96% | 47.04% | Net Selling | |||
| RAPT | RAPT THERAPEUTICS INC | $99.61M | 132,288,686 | 76.59% | 23.41% | ||||
| MGX | METAGENOMI INC | $56.45M | 37,383,472 | 28.70% | 33.25% | Net Selling | Net Selling | ||
| OSTX | OS THERAPIES INC | $42.24M | 21,663,811 | 0.67% | 30.48% | Net Selling | Net Selling | ||
| TNGX | TANGO THERAPEUTICS INC | $123.24M | 108,107,890 | 55.24% | 44.76% | Net Selling | |||
| DTIL | PRECISION BIOSCIENCES INC | $53.77M | 10,481,931 | 12.40% | 87.60% | Net Selling | Net Buying | ||
| GNLX | GENELUX CORP | $111.70M | 37,734,967 | 12.91% | 5.89% | Net Selling | |||
| IPA | IMMUNOPRECISE ANTIBODIES LTD | $14.75M | 32,851,233 | 5.81% | 0.00% | ||||
| SGMT | SAGIMET BIOSCIENCES INC | $104.96M | 32,195,345 | 44.49% | 55.51% | Net Selling | |||
| MRKR | MARKER THERAPEUTICS INC | $12.42M | 10,709,005 | 3.14% | 96.86% | Net Buying | |||
| SLN | SILENCE THERAPEUTICS PLC | $174.56M | 141,674,074 | 17.50% | 0.09% | ||||
| IOVA | IOVANCE BIOTHERAPEUTICS INC | $584.39M | 333,934,387 | 18.22% | 81.78% | Net Selling | Net Selling | ||
| ATOS | ATOSSA THERAPEUTICS INC | $105.53M | 129,170,004 | 23.17% | 14.77% | Net Buying | Net Buying | ||
| CRBU | CARIBOU BIOSCIENCES INC | $71.99M | 93,004,602 | 62.65% | 8.86% | Net Buying | Net Buying | ||
| KPTI | KARYOPHARM THERAPEUTICS INC | $50.58M | 8,416,008 | 63.18% | 36.82% | Net Selling | Net Selling | ||
| ELEV | ELEVATION ONCOLOGY INC | $20.31M | 59,215,795 | 67.50% | 20.02% | Net Selling | Net Selling | ||
| ACRS | ACLARIS THERAPEUTICS INC | $136.43M | 108,281,239 | 57.60% | 42.40% | Net Buying | Net Selling | ||
| CMPX | COMPASS THERAPEUTICS INC | $251.67M | 138,282,498 | 71.31% | 28.69% | Net Selling | Net Selling | ||
| AVTX | AVALO THERAPEUTICS INC | $43.33M | 10,671,934 | 8.48% | 91.52% | Net Selling | Net Selling | ||
| ALXO | ALX ONCOLOGY HOLDINGS INC | $22.55M | 53,444,020 | 73.37% | 26.63% | Net Buying | Net Selling | ||
| ONCY | ONCOLYTICS BIOTECH INC | $41.53M | 80,020,131 | 1.64% | 0.00% | ||||
| PDSB | PDS BIOTECHNOLOGY CORP | $54.48M | 45,395,851 | 9.34% | 26.04% | Net Buying | Net Buying | ||
| LRMR | LARIMAR THERAPEUTICS INC | $135.74M | 64,027,892 | 53.68% | 46.32% | ||||
| BDTX | BLACK DIAMOND THERAPEUTICS INC | $92.93M | 56,662,222 | 70.39% | 29.61% | Net Selling | Net Selling | ||
| CRBP | CORBUS PHARMACEUTICALS HOLDINGS INC | $78.93M | 12,236,767 | 46.25% | 53.75% | Net Buying | Net Selling | ||
| ESPR | ESPERION THERAPEUTICS INC | $158.16M | 198,199,462 | 63.57% | 20.63% | Net Selling | Net Selling | ||
| ADVM | ADVERUM BIOTECHNOLOGIES INC | $58.70M | 20,890,540 | 31.00% | 69.00% | Net Buying | Net Buying | ||
| SPRO | SPERO THERAPEUTICS INC | $34.66M | 55,900,641 | 28.05% | 64.20% | Net Selling | |||
| SKYE | SKYE BIOSCIENCE INC | $56.08M | 30,984,358 | 3.44% | 96.56% | Net Selling | |||
| ALLO | ALLOGENE THERAPEUTICS INC | $252.03M | 217,264,738 | 70.67% | 29.33% | Net Buying | Net Selling | ||
| NKTR | NEKTAR THERAPEUTICS | $109.62M | 186,103,588 | 71.41% | 14.11% | Net Selling | Net Selling | ||
| GRI | GRI BIO INC | $772.28k | 525,358 | 7.53% | 92.47% | ||||
| ATYR | ATYR PHARMA INC | $291.93M | 89,004,436 | 61.66% | 17.28% | Net Buying | Net Buying | ||
| CAPR | CAPRICOR THERAPEUTICS INC | $289.59M | 45,676,202 | 30.79% | 69.21% | Net Buying | Net Buying | ||
| LXEO | LEXEO THERAPEUTICS INC | $89.30M | 33,196,997 | 80.55% | 19.45% | Net Selling | Net Buying | ||
| CNTX | CONTEXT THERAPEUTICS INC | $70.06M | 89,704,194 | 81.14% | 1.29% | ||||
| ABOS | ACUMEN PHARMACEUTICALS INC | $59.36M | 60,573,425 | 70.15% | 17.11% | Net Selling | |||
| CING | CINGULATE INC | $17.03M | 4,245,713 | 1.20% | 98.80% | Net Selling | |||
| NKTX | NKARTA INC | $136.95M | 70,957,554 | 63.76% | 36.24% | Net Selling | |||
| KYTX | KYVERNA THERAPEUTICS INC | $91.18M | 43,214,918 | 56.40% | 43.60% | Net Buying | |||
| BMEA | BIOMEA FUSION INC | $61.24M | 37,572,250 | 57.06% | 42.94% | Net Buying | |||
| ATAI | ATAI LIFE SCIENCES NV | $275.65M | 198,306,455 | 7.33% | 36.99% | Net Buying | Net Buying | ||
| QNCX | QUINCE THERAPEUTICS INC | $44.88M | 44,001,643 | 11.08% | 88.92% | Net Buying | |||
| VNRX | VOLITIONRX LTD | $48.27M | 96,543,744 | 19.36% | 37.75% | Net Buying | Net Buying | ||
| ENGN | ENGENE HOLDINGS INC | $150.89M | 50,977,560 | 68.52% | 31.48% | Net Buying | |||
| LGVN | LONGEVERON INC | $20.11M | 15,009,306 | 2.98% | 97.02% | Net Selling | Net Selling | ||
| IPSC | CENTURY THERAPEUTICS INC | $46.21M | 86,045,033 | 42.30% | 45.63% | Net Selling | Net Selling | ||
| TCRX | TSCAN THERAPEUTICS INC | $71.87M | 56,590,627 | 73.39% | 25.38% | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.